DOVATO (DOLUTEGRAVIR/LAMIVUDINE): DATA FROM THE DYAD AND SOUND STUDY
PM-GB-HVX-WCNT-220003 | March 2024
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GSK via the GSK Reporting Tool or on 0800 221441.
If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.